Anthropic launches Claude for Life Sciences — enhanced model and new connectors
Action Required
Life science organizations can now leverage Claude to accelerate research, streamline workflows, and improve data analysis, potentially leading to faster drug development and reduced costs.
AI Impact Summary
Anthropic is expanding Claude's capabilities with a targeted release for the life sciences industry. This includes enhanced performance through the Sonnet 4.5 model, new connectors to scientific platforms like Benchling, BioRender, and PubMed, and the introduction of Agent Skills for consistent protocol execution. This expansion aims to support researchers, clinical coordinators, and regulatory affairs managers throughout the entire drug discovery and commercialization process, leveraging Claude's ability to analyze data, generate protocols, and facilitate collaboration.
Affected Systems
- Date
- Date not specified
- Change type
- capability
- Severity
- high